The Clinical and Administrative Core provides essential operational functions for the entire PPG. This Corewill recruit patients with frontotemporal dementia (FTD), semantic dementia (SD), progressive non-fluentaphasia (PNFA), progressive supranuclear palsy (PSP), corticobasaldegeneration (CBD), amyotrophiclateral sclerosis (ALS), Alzheimer's disease (AD), and normal control subjects. Each subject will receive acomprehensive evaluation measuring a broad range of neurological, neuropsychological,functional,neurobehavioral, and social-personality variables. In addition, subjects will be followed annually to collectlongitudinal data and maintain high enrollment in our autopsy program. Administrative functions of this Coreinclude the infrastructure for establishing policies and procedures, maintaining communication within thePPG and between the PPG and the scientific community, ensuring optimal utilization and monitoring of PPGresources, and ensuring the scientific and ethical integrity of all PPG practices. Once recruited into theClinical and Administrative Core, subjects will be referred to Projects 2 (Imaging; Dr. Weiner), 3 (Emotion;Dr. Levenson), 4 (Clinical Diagnosis; Dr. Miller), and 5 (Brain-Behavior; Dr. Rosen). In addition, bloodsamples will be sent to the Genetics Core (Dr.Geschwind) and autopsy tissue will be sent to the PathologyCore (Drs. Trojanowski and Lee). The Clinical and Administrative Core will also interact extensively with theData Management and Biostatistics Core (Dr.Fox) for data management, data quality, and data analysisfunctions.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Research Program Projects (P01)
Project #
5P01AG019724-07
Application #
7676829
Study Section
Special Emphasis Panel (ZAG1)
Project Start
Project End
Budget Start
2008-09-01
Budget End
2009-08-31
Support Year
7
Fiscal Year
2008
Total Cost
$568,456
Indirect Cost
Name
University of California San Francisco
Department
Type
DUNS #
094878337
City
San Francisco
State
CA
Country
United States
Zip Code
94143
Bergeron, David; Gorno-Tempini, Maria L; Rabinovici, Gil D et al. (2018) Prevalence of amyloid-? pathology in distinct variants of primary progressive aphasia. Ann Neurol 84:729-740
Pottier, Cyril; Zhou, Xiaolai; Perkerson 3rd, Ralph B et al. (2018) Potential genetic modifiers of disease risk and age at onset in patients with frontotemporal lobar degeneration and GRN mutations: a genome-wide association study. Lancet Neurol 17:548-558
Björkhem, Ingemar; Patra, Kalicharan; Boxer, Adam L et al. (2018) 24S-Hydroxycholesterol Correlates With Tau and Is Increased in Cerebrospinal Fluid in Parkinson's Disease and Corticobasal Syndrome. Front Neurol 9:756
Eser, Rana A; Ehrenberg, Alexander J; Petersen, Cathrine et al. (2018) Selective Vulnerability of Brainstem Nuclei in Distinct Tauopathies: A Postmortem Study. J Neuropathol Exp Neurol 77:149-161
Theofilas, Panos; Ehrenberg, Alexander J; Nguy, Austin et al. (2018) Probing the correlation of neuronal loss, neurofibrillary tangles, and cell death markers across the Alzheimer's disease Braak stages: a quantitative study in humans. Neurobiol Aging 61:1-12
Deleon, Jessica; Miller, Bruce L (2018) Frontotemporal dementia. Handb Clin Neurol 148:409-430
Burette, Alain C; Judson, Matthew C; Li, Alissa N et al. (2018) Subcellular organization of UBE3A in human cerebral cortex. Mol Autism 9:54
Rojas, Julio C; Bang, Jee; Lobach, Iryna V et al. (2018) CSF neurofilament light chain and phosphorylated tau 181 predict disease progression in PSP. Neurology 90:e273-e281
Zakrzewski, Jessica J; Datta, Samir; Scherling, Carole et al. (2018) Deficits in physiological and self-conscious emotional response to errors in hoarding disorder. Psychiatry Res 268:157-164
Hua, Alice Y; Sible, Isabel J; Perry, David C et al. (2018) Enhanced Positive Emotional Reactivity Undermines Empathy in Behavioral Variant Frontotemporal Dementia. Front Neurol 9:402

Showing the most recent 10 out of 607 publications